Heather C. Getz
Heather C. Getz's purchase track record
Heather C. Getz has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/14/2026 | TELA | $19K | pending | pending | — |
| 3/12/2026 | MYO | $65K | +99.1% | +88.9% | +13.8% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
MYO appoints Mary-Katherine McClure as Chief Commercial Officer. Myomo announced that Mary‑Katherine McClure has been named chief commercial officer. McClure will lead the company’s sales and marketing efforts and oversee commercial strategy. The addition of an experienced executive comes as the stock is trading near a long‑standing support level.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Butterfly Network Announces Long‑Term Alliance with VCOM and Gains New Coverage. Butterfly Network entered a long‑term partnership with the Edward Via College of Osteopathic Medicine to develop a new ultrasound education model. The collaboration aims to expand training tools for medical students. In addition, Canaccord Genuity started coverage on the stock, setting a price target of $10. The move reflects growing interest in Butterfly’s technology and its educational applications.
Transaction History
| TELA | ▲ Buy | Open Market | 12,500 | $8K | 8/17/2026 | View on chart |
| TELA | ▲ Buy | Open Market | 15,000 | $10K | 8/14/2026 | View on chart |
| TELA | ▲ Buy | Grant | 500,000 | $0 | 8/3/2026 | View on chart |
| MYO | ▲ Buy | Grant | 78,704 | $0 | 6/25/2026 | View on chart |
| MYO | ▲ Buy | Open Market | 20,000 | $14K | 3/16/2026 | View on chart |
| MYO | ▲ Buy | Open Market | 70,000 | $51K | 3/12/2026 | View on chart |
| MYO | ▲ Buy | Grant | 29,720 | $0 | 6/11/2025 | View on chart |
| BFLY | ▼ Sell | Open Market | 65,456 | $144K | 5/5/2025 | View on chart |
| BFLY | ▼ Sell | Tax Withholding | 282,649 | $856K | 3/3/2025 | View on chart |
| BFLY | ▲ Buy | Grant | 569,211 | $0 | 3/1/2025 | View on chart |
| BFLY | ▼ Sell | Open Market | 30,136 | $92K | 12/20/2024 | View on chart |
| MYO | ▲ Buy | Grant | 12,034 | $0 | 6/5/2024 | View on chart |
| BFLY | ▼ Sell | Open Market | 59,848 | $57K | 5/3/2024 | View on chart |
| BFLY | ▼ Sell | Open Market | 81,448 | $93K | 3/11/2024 | View on chart |
| BFLY | ▲ Buy | Grant | 1,323,529 | $0 | 3/6/2024 | View on chart |
| BFLY | ▼ Sell | Open Market | 66,142 | $67K | 1/5/2024 | View on chart |
| BFLY | ▲ Buy | Grant | 200,000 | $0 | 7/13/2023 | View on chart |
| BFLY | ▼ Sell | Open Market | 65,577 | $143K | 7/5/2023 | View on chart |
| BFLY | ▼ Sell | Open Market | 64,536 | $128K | 5/3/2023 | View on chart |
| BFLY | ▲ Buy | Grant | 600,000 | $0 | 3/1/2023 | View on chart |
| BFLY | ▲ Buy | Grant | 285,000 | $0 | 3/1/2023 | View on chart |
| BFLY | ▲ Buy | Grant | 628,491 | $0 | 5/2/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Craig-Hallum initiates coverage on TELA Bio with $2 target
Craig-Hallum has started tracking TELA Bio, assigning a price target of $2. This new analyst note aligns with the current average analyst target of $2.08. The stock is currently trading above its 52-week low of $0.50, with recent technical indicators showing momentum near the upper end of its recent range.
Craig-Hallum initiates coverage on TELA Bio with $2 target. Craig-Hallum has started tracking TELA Bio, assigning a price target of $2. This new analyst note aligns with the current average analyst target of $2.08. The stock is currently trading above its 52-week low of $0.50, with recent technical indicators showing momentum near the upper end of its recent range.